Advances in radiation therapy of head and neck cancer

Aron Popovtzer*, Avraham Eisbruch

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Abstract

Head and neck cancer is the fifth most common cancer in the USA. Although there have been major improvements in surgical and radiation techniques, the overall survival has not changed significantly in the last decade. The major changes occurring in recent years have been in the ability to preserve organs and to improve quality of life. The advances in radiation therapy include 3D conformal radiotherapy, intensity-modulated radiotherapy and, more recently, imaging-guided radiotherapy. In advanced head and neck cancer the addition of chemotherapy to radiation has concomitantly improved survival and facilitated higher rates of organ preservation. Clinical trials are needed to develop better strategies customized to subgroups defined by individual biological risk and imaging findings.

Original languageEnglish
Pages (from-to)633-644
Number of pages12
JournalExpert Review of Anticancer Therapy
Volume8
Issue number4
DOIs
StatePublished - Apr 2008
Externally publishedYes

Keywords

  • Biomarkers
  • CTV
  • Chemoradiation
  • GTV
  • Head and neck cancer
  • IMRT
  • Organs of risk
  • Targeted therapy

Fingerprint

Dive into the research topics of 'Advances in radiation therapy of head and neck cancer'. Together they form a unique fingerprint.

Cite this